Risk factors for relapse of steroid-sensitive nephrotic syndrome in children
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261135Keywords:
Nephrotic syndrome, Relapse, Remission, Renal function, SteroidAbstract
Background: The management of nephrotic syndrome (NS) is often challenged in relapse cases. Authors aimed to find out the risk factors for relapse of steroid-sensitive nephrotic Syndrome.
Methods: This cross-sectional study was carried out in the department of pediatrics, ICMH, Dhaka, from July 2020 to June 2021. A total of 40 admitted as well as follow-up relapse cases of steroid-sensitive NS were enrolled and proceeded to clinical and laboratory evaluation.
Results: The mean onset of NS was 3.86±2.35 years. Frequently relapsing NS (FRNS) was found in 14 (35.0%) cases and infrequently relapsing NS (IFRNS) was 26 (65.0%) cases. The majority of children responded within 7 days to initial steroid therapy (75% in IFRNS group and 50% from FRNS group); again, 50% of children with FRNS needed a longer time (≥7 days) to respond to initial steroid therapy. RTI and UTI were higher in FRNS, whereas viral fever and diarrhea were higher in IFRNS. The age of onset of NS, mean serum albumin, serum cholesterol and serum creatinine were not statistically significant compared with the type of relapse. Time needed to respond with initial steroid therapy at 1st attack of NS had a statistically significant difference when compared with the type of relapse in children with SSNS.
Conclusions: RTI and UTI were seen to occur in higher frequency in relapse cases of NS. A longer time taken to achieve remission during the first episode was significantly associated with FRNS.
References
Johnson RJ, Feehally J, Floege J. Comprehensive clinical nephrology E-Book. Elsevier Health Sciences. 2014.
Aier A, Pais P, Raman V. Psychosocial functioning and health-related quality of life in children with nephrotic syndrome: preliminary findings. J Indian Assoc Child Adol Mental Health. 2022;18(4):306-14.
Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol. 2015;19(1):6-33.
Esfahani ST, Madani A, Asgharian F, Ataei N, Roohi A, Moghtaderi M, et al. Clinical course and outcome of children with steroid-sensitive nephrotic syndrome. Pediat Nephrol. 2011;26(7):1089-93.
Lombel RM, Gipson DS and Hodson EM. Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediat Nephrol. 2013;28(3):415-26.
Shalhoub R. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. The Lancet 1974;304(7880):556-60.
Jamin A, Dehoux L, Dossier C, Fila M, Heming N, Monteiro RC. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin Exp Immunol. 2015;182(3):332-45.
Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci. 2004;107(2):125-36.
Clement LC, Avila-Casado C, Macé C, Soria E, Bakker WW, Kersten S, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nature Med. 2011;17(1):117-22.
Brenchley PE. Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dialy Transplant. 2003;18(6):21-5.
Teeninga N, Kist-van Holthe JE, Nauta J. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol. 2012;24:149–59.
Constantinescu AR, Shah HB, Foote EF and Weiss LS. Predicting first-year relapses in children with nephrotic syndrome. Pediatrics. 2004;105(3):492-5.
Takeda A, Takimoto H, Mizusawa Y and Simoda M. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediat Nephrol. 2001;16(11):888-93.
Balaji J, Kumaravel KS, Punitha P and Rameshbabu B. Risk factors for relapse in childhood steroid-sensitive nephrotic syndrome. Indian J Child Health. 2017;4(3):322-6.
Minj SS, Rathi S, Kondekar S and David JJ. Study of risk factors for relapse in frequently versus infrequently relapsing nephrotic syndrome in the 1-18 year age group: a combined prospective, retrospective cohort analytical observational study. Int J Contemp Pediatr. 2019;6(2):803-10.
Sarker MN, Islam MMSU, Saad T, Shoma FN, Sharmin LS, Khan HA, et al. Risk factor for relapse in childhood nephrotic syndrome-a hospital based retrospective study. Faridpur Medical College J. 2012;7(1):18-22.
Uwaezuoke SN, Okafor HU, Eneh CI and Odetunde OI. The triggers and patterns of relapse in childhood idiopathic nephrotic syndrome: a retrospective, descriptive study in a tertiary hospital, south-east Nigeria. J Clin Nephrol Res. 2016;3(1):1032.
Albar H, Bilondatu F, Daud D. Risk factors for relapse in pediatric nephrotic syndrome. Paediat Indonesia. 2018; 58(5):238-41.
Ali SH, Ali AM, Najim AH. The predictive factors for relapses in children with steroid-sensitive nephrotic syndrome. Saudi J Kid Dis Transplant. 2016; 27(1):67-72.
Andersen RF, Thrane N, Noergaard K, Rytter L, Jespersen B and Rittig S. Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome. Pediat Nephrol. 2010;25(7):1299-304.
Ali EM, Elhadi NM, Abdelraheem MB, Ellidir RA. Childhood steroid-sensitive nephrotic syndrome: characteristics and predictors of relapses (A Study at a Single Center in Khartoum). Sudan J Med Sci. 2018;13(3):133-43.
Rahi K, Al-Badri AAS, Salih BJ, Hasan FO. Childhood nephrotic syndrome, frequent and infrequent relapses and risk factors for relapses. Iraqi Acad Sci J. 2009;8(3):291-5.
Noer MS. Predictors of relapse in steroid-sensitive nephrotic syndrome. Southeast Asian J Trop Med Publ Heal. 2005;36(5):1313-20.
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome. J Trop Pediat. 2013;59(5):343-9.
Downloads
Published
How to Cite
Issue
Section
